Cargando…
Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation?
Autores principales: | Mitchell, Jenee, Kannourakis, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596980/ https://www.ncbi.nlm.nih.gov/pubmed/34146441 http://dx.doi.org/10.1111/apa.15995 |
Ejemplares similares
-
Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
por: Mitchell, Jenée, et al.
Publicado: (2021) -
Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis
por: Mitchell, Jenée, et al.
Publicado: (2018) -
Polyclonal T-Cells Express CD1a in Langerhans Cell Histiocytosis (LCH) Lesions
por: West, Jennifer A., et al.
Publicado: (2014) -
Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions
por: Mitchell, Jenée, et al.
Publicado: (2022) -
Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin‐23
por: Kvedaraite, Egle, et al.
Publicado: (2020)